BCEIE › News › KOVAI

Approval

Kovai Medical Center & Hospital: The Board of Directors has approved the extension of period to transfer the permission in the name of the…

Kovai Medical Center & Hospital (KOVAI) filed a disclosure titled "The Board of Directors has approved the extension of period to transfer the permission in the name of the Company for conducting". The company is valued at about ₹6,707 crore.

BCEIE News Desk · Published 11 Nov 2026, 07:24 pm IST · Filing received 11 Nov 2026, 07:09 pm IST

What happened

Kovai Medical Center & Hospital (KOVAI) filed a disclosure with the exchanges on 11 November 2026 at 07:09 PM titled "The Board of Directors has approved the extension of period to transfer the permission in the name of the Company for conducting".

Company snapshot

Kovai Medical Center & Hospital is a small-cap company, with a market value of about ₹6,707 crore.

The stock last traded at ₹6,129, against a 52-week range of ₹2,576.7–₹6,444 (4.9% below the high).

Before this filing the shares had moved +2.2% over the month and −2.5% over three months. Average daily turnover over the last 20 sessions was about ₹2.46 crore.

Promoters held 56.52% at the end of Q1 FY27. Foreign institutions owned 1.25% and domestic institutions 4.25%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2637457.252.3
Q2 FY2639258.953.79
Q3 FY264076559.42
Q4 FY2641459.754.55
Q1 FY2743169.163.14

What history shows

BCEIE has no earlier approval filing from this company on record since May 2026.

Market-wide, 1,614 approval filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 48% rising.

Past reactions describe what happened before; they are not a forecast.

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Kovai Medical Center & Hospital Limited